Literature DB >> 8097949

Enhancement of airway reactivity to histamine by isoprenaline and related beta-adrenoceptor agonists in the guinea-pig.

B C Galland1, J G Blackman.   

Abstract

1. The effect of isoprenaline, adrenaline and salbutamol on airway reactivity to histamine was observed in anaesthetized, ventilated guinea-pigs. Airway reactivity was determined before and 20 min and 90 min after a 30-min i.v. infusion of each agonist by constructing cumulative dose-response curves from breath-by-breath measurements of the effect of different rates of i.v. infusion of histamine on lung resistance (RL) and dynamic compliance (Cdyn). 2. (+/-)-Isoprenaline infused i.v. for 30 min at a rate of 0.4 mumol h-1 kg-1 caused bronchodilatation and a fall in blood pressure. Recovery to starting values of RL and Cdyn occurred within 20 min of stopping the infusion. 3. Reactivity to histamine was greatly enhanced when measured 20 min and 90 min after stopping the infusion of (+/- )-isoprenaline. This was not an effect of the prior infusion of histamine or of the dissolving solution. 4. Infusion of (-)-isoprenaline for 30 min at a rate of 0.2 mumol h-1 kg-1 also enhanced reactivity to histamine. However, enhancement of reactivity to histamine was not demonstrable after infusion of (+)-isoprenaline at equal or higher dose rates. 5. Infusions of bronchodilator concentrations of adrenaline and salbutamol also enhanced airway reactivity to histamine, but the bronchodilator effect of salbutamol lasted longer than that of isoprenaline or adrenaline and the development of hyperreactivity was delayed. 6. After acute bilateral vagotomy, infusion of (+/- )-isoprenaline enhanced airway reactivity but only at the highest dose of histamine. 7. (+/-)-Isoprenaline did not enhance contractile responses to histamine in isolated preparations of first branch bronchi. 8. We conclude that the bronchodilator effect of activating beta-adrenoceptors in the airways of guinea pigs is followed by a more persistent state of hyperreactivity to histamine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097949      PMCID: PMC1908158          DOI: 10.1111/j.1476-5381.1993.tb13499.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Mechanics of respiration in unanesthetized guinea pigs.

Authors:  M O AMDUR; J MEAD
Journal:  Am J Physiol       Date:  1958-02

2.  Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol.

Authors:  C P van Schayck; S J Graafsma; M B Visch; E Dompeling; C van Weel; C L van Herwaarden
Journal:  J Allergy Clin Immunol       Date:  1990-11       Impact factor: 10.793

3.  Increased sensitivity to anaphylactic shock in guinea pigs induced by prolonged treatment with epinephrine prior to challenge.

Authors:  S R Izard; E C Henson; A D Collins; J G Brunson
Journal:  J Allergy       Date:  1971-06

4.  Asthma induced by adrenergic aerosols.

Authors:  R E Reisman
Journal:  J Allergy       Date:  1970-09

5.  Adverse effects of inhalation of excessive amounts of nebulized isoproterenol in status asthmaticus.

Authors:  T E Van Metre
Journal:  J Allergy       Date:  1969-02

6.  Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline.

Authors:  A S Vathenen; A J Knox; B G Higgins; J R Britton; A E Tattersfield
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

7.  On the measurement of vascular and respiratory smooth muscle responses in vitro.

Authors:  C S Hooker; P J Calkins; J H Fleisch
Journal:  Blood Vessels       Date:  1977

8.  Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

Authors:  J Kraan; G H Koëter; T W vd Mark; H J Sluiter; K de Vries
Journal:  J Allergy Clin Immunol       Date:  1985-10       Impact factor: 10.793

9.  Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).

Authors:  M E Conolly; D S Davies; C T Dollery; C F George
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

10.  Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma.

Authors:  K F Kerrebijn; E E van Essen-Zandvliet; H J Neijens
Journal:  J Allergy Clin Immunol       Date:  1987-04       Impact factor: 10.793

View more
  7 in total

Review 1.  Anomalous effects of albuterol and other sympathomimetics in the guinea pig.

Authors:  J Morley
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 2.  Albuterol. A pharmaceutical chemistry review of R-, S-, and RS-albuterol.

Authors:  R P Bakale; S A Wald; H T Butler; Y Gao; Y Hong; X Nie; C M Zepp
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 3.  Enantioselective disposition of albuterol in humans.

Authors:  D W Boulton; J P Fawcett
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

4.  Human trachealis and main bronchi smooth muscle are normoresponsive in asthma.

Authors:  Gijs Ijpma; Linda Kachmar; Oleg S Matusovsky; Jason H T Bates; Andrea Benedetti; James G Martin; Anne-Marie Lauzon
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

5.  Asthma treatment through the beta receptor: lessons from animal models.

Authors:  Erik P Riesenfeld; Charles G Irvin
Journal:  Front Biosci (Elite Ed)       Date:  2011-06-01

6.  Occupational asthma in salbutamol process workers.

Authors:  R M Agius; A G Davison; E R Hawkins; A J Newman Taylor
Journal:  Occup Environ Med       Date:  1994-06       Impact factor: 4.402

Review 7.  The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.

Authors:  M R Sears; D R Taylor
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.